Nalaganje...

Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious disease

Monoclonal antibodies (mAbs) have revolutionized the diagnosis and treatment of many human diseases and the application of combinations of mAbs has demonstrated improved therapeutic activity in both preclinical and clinical testing. Combinations of antibodies have several advantages such as the capa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Curr Opin Immunol
Main Authors: Corti, Davide, Kearns, Jeffrey D
Format: Artigo
Jezik:Inglês
Izdano: Elsevier Ltd. 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7127534/
https://ncbi.nlm.nih.gov/pubmed/26995095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2016.03.001
Oznake: Označite
Brez oznak, prvi označite!